Cytomed Therapeutics Ltd. (GDTC)
Market Open
11 Aug, 17:04
NASDAQ (CM) NASDAQ (CM) Primary 
XFRA $
0. 82
+0.02
+2.7122%
$
9.72M Market Cap
- P/E Ratio
- Div Yield
2,449 Volume
-0.26 Eps
$ 0.8
Previous Close Want to track GDTC and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Cytomed Therapeutics Ltd. (GDTC) Statistics
Valuation metrics
Market Cap 9.72M
Enterprise value 10.81M
Trailing P/E (ttm) -2.6
Forward P/E -
PEG ratio 0.16
Price/Sales (ttm) 19.32
Price/Book (mrq) 1.89
Enterprise Value/Revenue 16.82
Enterprise Value/EBITDA -2.05
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 29K
Average volume (90 days) 88.95K
Price summary
52-Week low 0.68
52-Week high 3.68
Beta -
50-Day moving average 0.96
200-Day moving average 1.01
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -7.55%
Operating margin -6.72%
Operational effectiveness
Return on assets -0.61%
Return on equity -0.71%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.05
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.41
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.18
Total debt (mrq) -
Total Debt/Equity (mrq) 0.07
Current ratio (mrq) 5.17%
Book value per share (mrq) 0.58
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
